$3.120
-0.087 (-2.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CCCC Prediction & Forecast by Similar Chart Analysis
Alphio's CCCC stock price prediction model matches the current C4 Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.14 (+0.56%). The 1-week path is $3.16 (+1.21%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy C4 Therapeutics Inc Stock?
C4 Therapeutics Inc is a good buy right now, given its current price of $3.21 and a significant upside potential indicated by JPMorgan's $10 price target. Additionally, the company has shown a 66.32% year-to-date change and a 7.72% increase over the past five days, suggesting positive momentum. However, the main risk is its ongoing net losses, with a reported net loss of $23.63 million in Q2 2026.
CCCC stock price ended at $3.12 on Wednesday, after losing -2.80%
C4 Therapeutics Inc (CCCC) last closed at $3.1199999, losing -2.80%. These facts feed the 1-day and 1-week CCCC price prediction above.
Forecast Drivers
C4 Therapeutics Inc (CCCC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CCCC, ranked by similarity.
Seasonality analysis for CCCC
Historically the probability of a positive November return for CCCC is 7.14%. March offers the highest probability of a positive month at 66.67%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CCCC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.41 | $1.75 | $2.13 | -43.76% |
| Dec 2026 | $1.66 | $1.97 | $2.05 | -36.71% |
In 2026, C4 Therapeutics Inc (CCCC) is projected to range from $1.41 to $2.13.
C4 Therapeutics Inc 2026 monthly forecast
In Nov 2026, C4 Therapeutics Inc is projected to average $1.75, with a low of $1.41 and high of $2.13.
In Dec 2026, C4 Therapeutics Inc is projected to average $1.97, with a low of $1.66 and high of $2.05.
Related articles
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
- Democratic Sweep Sends Stocks Soaring: Dow Posts Best Post-Midterm Rally in 44 Years Amid AI Sector US stocks surged after Democrats swept the 2026 midterms. The Dow jumped 1,569 points for its best post-election day since 1982 as markets cheered political clarity.
- Stock Market Surges After 2026 Midterms: What the Democratic Sweep Means for Your PortfolioThe stock market rallied after Democrats won the 2026 midterms. Discover what the election means for investors, tech stocks, and the S&P 500 outlook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.